Volitionrx limited announces proposed underwritten public offering of common stock

Henderson, nev. , feb. 16, 2023 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition" or the "company"), a multi-national epigenetics company, announced today that it has commenced an underwritten public offering of shares of its common stock.

VNRX Ratings Summary

VNRX Quant Ranking